Nef-301

· Everest Medicines (Singapore) Pte. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nef-301, covering 2024-11-12 to 2024-11-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety in Chinese Patients with Immunoglobulin a Nephropathy (IgAN) Who Have Completed Study Nef-301 [Phase 3]

See pricing